| NCT Number | NCT05646316 |
| Lead Sponsor | NRG Oncology
Collaborators: National Cancer Institute (NCI) |
| Conditions | Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 |
| Enrollment | 428 participants |
| Start Date | 2022-12-07 |
| Primary Completion | 2026-10-31 (estimated) |
| Study Completion | 2026-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-07 |